- Zoek vacatures
- Liege
- hospitalist physician
Hospitalist physician Vacatures in Liege
- Gesponsord
Medical Science Liaison (France or Belgium)
Summit Therapeutics Sub, Inc.France, Luik, BelgiumMedical Science Liaison (France or Belgium)
Summit Therapeutics Sub, Inc.France, Luik, BelgiumCareer Opportunities with Summit Therapeutics Sub, Inc.
A great place to work.
Careers At Summit Therapeutics Sub, Inc.
Current job opportunities are posted here as they become available.
Medical Science Liaison (France or Belgium)
To build a viable, long-lasting health care organization that assumes full responsibility for designing, developing, trial execution and enrollment, regulatory submission and approval, as well as successful commercialization of patient, physician, caregiver, and societal-friendly medicinal therapy intended to improve quality of life, increase potential duration of life, and resolve serious medical healthcare needs. To identify and control promising product candidates based on exceptional scientific development and administrative expertise, develop our products in a rapid, cost-efficient manner, and to engage commercialization and / or development partners when appropriate.
We accomplish this by building a team of world-class professional scientists and business administrators that apply their experience and knowledge to this mission.
We have in-licensed Ivonescimab, which is a novel, potential first-in-class investigational bispecific antibody combining the effects of immunotherapy via a blockade of PD-1 with the anti-angiogenesis effects associated with blocking VEGF into a single molecule.
We initiated phase-III clinical studies in Europe and in North America in the following NSCLC indications :
- Ivonescimab combined with chemotherapy in patients with epidermal growth factor receptor (EGFR)-mutated, locally advanced or metastatic non-squamous NSCLC who have progressed after treatment with a third-generation EGFR tyrosine kinase inhibitor (“HARMONi”)
- Ivonescimab combined with chemotherapy in first-line metastatic squamous NSCLC patients (“HARMONi-3”)
- Ivonescimab in first-line PD-L1 High, Metastatic NSCLC (“HARMONi-7”)
Ivonescimab is an investigational therapy that is not approved by any regulatory authority other than China’s National Medical Products Administration (NMPA).
Overview of Role :
The Medical Science Liaison (MSL) is a field-based scientific expert specializing in Immuno-Oncology and related treatment options. They play a strategic role in supporting Summit’s scientific and business objectives throughout the oncology product lifecycle. MSLs act as the primary scientific communicators for Summit within their designated regions, engaging with healthcare professionals and supporting clinical site activities.
Combining strong business acumen, clinical expertise, and market awareness, MSLs serve as vital conduits of information to various stakeholders within Summit. Depending on therapeutic needs and product life cycles, their responsibilities may include clinical development and pipeline support.
Role and Responsibilities :
Experience, Education and Specialized Knowledge and Skills :
Proficiency in English and French is required.
Understanding, analyzing, and communicating complicated scientific concepts and data.
Meeting healthcare industry representative (HCIR) credentialing requirements to enter facilities and organizations within the assigned territory. These may include background checks, drug screens, and proof of immunization / vaccination for various diseases.
J-18808-Ljbffr